Maria Trachana Selected Research

canakinumab

12/2020

Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Trachana Research Topics

Disease

10	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2024 - 06/2008
2	Familial Mediterranean Fever (Periodic Disease) 01/2022 - 09/2019
2	Lupus Nephritis 01/2022 - 01/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 03/2013
2	Rheumatic Diseases (Rheumatism) 01/2020 - 06/2008
2	Nephritis 01/2019 - 03/2013
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Fever (Fevers) 12/2020
1	Autoimmune Diseases (Autoimmune Disease) 06/2020
1	Proteinuria 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Inflammation (Inflammations) 09/2019
1	Disease Progression 01/2018
1	Latent Tuberculosis 10/2017
1	Necrosis 10/2017
1	Dermatomyositis (Dermatopolymyositis) 02/2016
1	Infections 02/2016
1	Rheumatoid Arthritis 10/2011
1	Cicatrix (Scar) 08/2011
1	Keratitis 08/2011
1	Pityriasis Lichenoides (Pityriasis Lichenoides et Varioliformis Acuta) 02/2010
1	Thyroiditis 06/2008

Drug/Important Bio-Agent (IBA)

2	SteroidsIBA 01/2022 - 08/2011
2	GlucocorticoidsIBA 12/2020 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 02/2016 - 02/2010
2	Etanercept (Enbrel)FDA Link 08/2013 - 06/2008
1	Abatacept (Orencia)FDA Link 01/2024
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Ribonucleases (Ribonuclease)IBA 01/2022
1	canakinumab FDA Link 12/2020
1	C-Reactive ProteinIBA 10/2020
1	Adalimumab (Humira)FDA Link 10/2020
1	Biomarkers (Surrogate Marker)IBA 06/2020
1	Calcineurin InhibitorsIBA 01/2020
1	AldosteroneIBA 01/2020
1	AngiotensinsIBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Edetic Acid (EDTA)FDA Link 01/2020
1	ReninIBA 01/2020
1	Colchicine FDA LinkGeneric 09/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	ametantrone (HAQ)IBA 11/2017
1	Tuberculin (PPD)IBA 10/2017
1	InterferonsIBA 10/2017
1	GoldIBA 10/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2016
1	Prednisone (Sone)FDA LinkGeneric 02/2016
1	Rituximab (Mabthera)FDA Link 03/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011
1	GhrelinIBA 10/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2011
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 07/2010
1	AutoantibodiesIBA 06/2008
1	Infliximab (Remicade)FDA Link 06/2008
1	HLA-DQB1 antigen (HLA DQB1)IBA 06/2008
1	HLA-DRB1 Chains (HLA DRB1)IBA 06/2008

Therapy/Procedure

1	Telerehabilitation 12/2023
1	Drug Tapering 12/2020
1	Precision Medicine 06/2020
1	Therapeutics 01/2020
1	Biological Therapy 01/2018
1	Time-to-Treatment 02/2016